[PDF] - INFECTIONS IN KIDS TO TREAT OR NOT TO TREAT? I HAVE NOTHING TO PDF Document

SLIDE 1

3/14/18 1

INFECTIONS IN KIDS

TO TREAT OR NOT TO TREAT?

Andi Marmor, MD, MSED Professor of Pediatrics University of California, San Francisco Zuckerberg San Francisco General Hospital

I HAVE NOTHING TO DISCLOSE.

Three Common Presentations

u Fever without a source (SBI) u Urinary Tract Infections u Pharyngitis u Pertussis u Community Acquired PNA

FEVER DIFFICULTY BREATHING RASH

u Infections and Mimickers

Case Presentation: Infant with Fever

uXanadu is 2 week old girl with a fever uNo symptoms to suggest a source on

exam/history

uVS: T 38.5, P 150, R 40’s, o/w WNL uExam: well-appearing, no focal findings

to suggest source for fever

SLIDE 2

3/14/18 2

The most likely cause of Xanadu’s fever is:

A.

Viral infection

B.

Urinary tract infection

C.

Serious bacterial infection (SBI) (bacteremia/meningitis)

D.

HSV infection

The most likely cause of Xanadu’s fever is:

A.

Viral infection

B.

Urinary tract infection

C.

Serious bacterial infection (SBI)(bacteremia/meningitis)

D.

HSV infection

THE FEBRILE INFANT

Everything you need to know about SBI in febrile infants - on ONE SLIDE

Schwartz, 2009, Gomez 2010, Greenhow, 2014

2-3%

E.Coli>GBS>S. aureus >enterococcus, S pneumo

13-18% <1%

Greenhow, 2014

E. Coli

E.Coli/GBSèS. pneumo

SLIDE 3

3/14/18 3

Fever without a source (FWS): Infants <30 days

uAppearance and lab criteria do not reliably

rule out UTI/SBI in this age group

uUrine, blood, CSF, empiric abx

Fever without a source (FWS): Infants <30 days

uAppearance and lab criteria do not reliably

rule out UTI/SBI in this age group

uUrine, blood, CSF, empiric abx

treating with cefotaxime alone

¤DO NOT treat with gentamicin alone

FWS: Infants 30-90 days

uUTI still the most common bacterial source,

ther SBI less likely

uViral source more reliable ¤Named viral syndromes or + rapid viral test

(flu, RSV) èSBI unlikely

¤Consider testing for UTI uInflammatory markers (CBC/CRP/PCT)

helpful in select infants

¤Well appearing, neg UA AND no viral source

Approach to Infant with FWS

no

SLIDE 4

3/14/18 4

Case Continued

uSince Xanadu is less than 30 days, and

has no source for her fever, you obtain a UA/urine cx and blood cultures and perform an LP

uHer UA is positive for LE and nitrites uNow what do you do?

URINARY TRACT INFECTIONS (“PYELONEPHRITIS”) Risk of UTI in Infants with FWS

2 4 6 8 10 12 14 16 18 20 1 m 3m 6m 12m 18m

Girls Uncirc Boys Circ Boys

Which infants <3 mo should we test for UTI?

2 4 6 8 10 12 14 16 18 20 1 m 3m 6m 12m 18m

Girls Uncirc Boys Circ Boys

ALL infants < 3 mo, T>38

Testing threshold ~2- 3%

SLIDE 5

3/14/18 5

2 4 6 8 10 12 14 16 18 20 1 m 3m 6m 12m 18m

Girls Uncirc Boys Circ Boys

Testing threshold ~5%

All Girls Circ boys <6 mo Uncirc boys <12 mo

Which infants >3 mo* should we test for UTI?

*T≥39 for ≥48hrs

Who should we test for UTI?

u All infants with FWS < 3 mo of age u Girls > 3 mo of age ¤FWS (>39) and < 24 months u Boys > 3 mo of age ¤Circumcised: FWS (>39) and < 6 mo ¤Uncircumcised: FWS (>39) and < 12 mo u Additional Risk Factors: ¤Length of fever (> 2 days) ¤Race (non-black)

Diagnostic Dilemmas

u Collection of urine ¤By catheter for: nInfants < 3 mo of age (high risk) nIll-appearing/getting antibiotics ¤Consider bag collection for: nLow-risk infant (circ boy> 3 mo, girl/boy>1 year) nIf UA +, consider cath for culture u Results: ¤+ UA: start empiric treatment, send for cx ¤Neg UA: UTI very unlikely, even in young infants nConsider sending for culture in high risk neonate

Treatment

u Empiric treatment based on local E. Coli resistance

¤PO cephalexin safe, tasty, narrow spectrum ¤IV if <2 mo, toxic or not tolerating PO ¤Total course: 7-14 days (for pyelo) uImaging after UTI ¤U/S in infants <3 mo, older kids if recurrent ¤Voiding Cystourethrogram (VCUG) only if high

grade VUR/obstruction on U/S

Roberts 2011;Pediatrics128(3):595–610

SLIDE 6

3/14/18 6

Case Continued

uXanadu’s 6 yo brother Zaffre also has a

fever, and is complaining of a sore throat

uHis temp is 38.9, he has tender cervical

LAN and no cough or runny nose

www.accesspediatrics.com

What is Zaffre’s “modified Centor score?”

A.

1

B.

2

C.

3

D.

4

E.

5

Modified Centor Score

u1 point each: ¤Exudate or swelling on tonsils ¤Tender/swollen ant cervical LN’s ¤Temp > 38C ¤Cough absent ¤Age 3-14

____________ Max score = 5

Modified Centor Score

u1 point each: qExudate or swelling on tonsils?? þTender/swollen ant cervical LN’s þTemp > 38C þCough absent þAge 3-14

____________ Score = 4-5

SLIDE 7

3/14/18 7

What does this mean?

uWhat is Zaffre’s prior probability of a +

GAS culture?

A.

~25%

B.

~50%

C.

~75%

D.

~90%

What does this mean?

uWhat is Zaffre’s prior probability of a +

GAS culture?

A.

~25%

B.

~50% - this is why we test, don’t treat!

C.

~75%

D.

~90%

uWhen should you treat empirically? ¤Scarlet fever, cx + sibling, etc

Case Presentation: 3 yo with cough

uAmaranth is a 3 yo who presents with 2

weeks of cough, keeps her awake, and

ccasional post-tussive vomiting

uShe has a PMH of bronchiolitis (6 mo) and

is up to date for age on vaccinations

uVS: T 38.2, P 130, RR 42, O2 sat 95% uHer mother wants to know if this could be

“the whooping cough”

PERTUSSIS

SLIDE 8

3/14/18 8

Pertussis Epidemiology

Tdap Acellular pertussis

Phases of Pertussis

PHASE TIME COURSE DESCRIPTION Catarrhal 1-2 weeks Mild fever, cough, rhinorrhea Paroxysmal 1-6 weeks Older infants/children: Paroxysms, whoop, post-tussive emesis Young infants: apnea, cyanosis, bradycardia, poor feeding Convalescent Weeks-Months Improvement in severity and frequency of coughing episodes

Slide courtesy of Ellen Laves, MD

Pertussis: Clinical Diagnosis

uCough lasting >2 weeks + 1of the following: ¤Apnea* ¤Paroxysms of coughing ¤Inspiratory “whoop” ¤Post-tussive vomiting (least specific)

cdc.gov/pertussis

Older children *May occur without cough Neonates/young Infants

Pertussis: Laboratory Confirmation

uLab confirmation ONLY in those with

signs/symptoms consistent with pertussis

uPosterior NP specimen (not pharynx/ant NP) uPCR for pertussis ¤False positives may occur uCulture + for B. Pertussis ¤Most SPECIFIC test uMost sensitive in first 3 weeks

cdc.gov/pertussis

SLIDE 9

3/14/18 9

Pertussis: Treatment

u Major benefits: ¤Prevent severe disease* in those at risk ¤Prevent spread to high risk (HR) patient u Empiric treatment: high suspicion and/or HR ¤Infants <1 year (< 3mo, preemie at highest risk) ¤Pregnant women near term ¤Unimmunized or underimmunized u Test and treat if +: ¤HR but low clinical suspicion ¤Patient LR but has HR contacts

*Only treatment BEFORE paroxyms may shorten course

Case Continued

uAmaranth’s vaccination status and non-

specific clinical symptoms make pertussis less likely

uHowever, her RR (42) and O2 sat (95%)

make you concerned for pneumonia

¤Well-appearing, in minimal resp distress

aside from tachypnea

¤Decreased breath sounds with crackles over

the LLL

What is the RECOMMENDED next step?

A.

Obtain a PA and lateral CXR

B.

Obtain a blood culture and CBC

C.

Obtain a sputum culture

D.

Start PO amoxicillin and discharge with close follow up

E.

Start IV cefuroxime and admit

PEDIATRIC COMMUNITY ACQUIRED PNEUMONIA

SLIDE 10

3/14/18 10

Pediatric CAP: Diagnosis

uClinical ¤Symptoms of acute illness (ie: fever) + resp

distress (tachypnea*, retractions, hypoxia) AND

¤Focal lung findings on exam OR on CXR uImaging ¤Chest x-ray NOT recommended routinely in

utpatients

¤Does not distinguish between pathogens (viral,

atypical, etc)

Bradley JS, et al. Clin Infect Dis. 2011

*MOST SENSITIVE sign

Pediatric CAP: Labs

u Routine lab testing NOT recommended u Blood cultures: ¤ Clinically worsening or hosp with mod/severe disease u Viral testing (flu, RSV) ¤ IF no evidence of bacterial co-infection u CBC/CRP ¤ Not recommended u Testing for Mycoplasma pneumoniae, S. pneumo ¤ If available, may guide antibiotic selection

Bradley JS, et al. Clin Infect Dis. 2011

Pediatric CAP: Causes

¤ Viral is most common ¤ < 2 yrs: S. pneumoniae, C.

Trachomatis

¤ 2-5 yrs S. pneumoniae >

M. pneumoniae, H

influenzae, C. pneumoniae

u M. pneumoniae> C.

pneumoniae, S. pneumoniae

2 MO TO 5 YRS: OVER 5 YEARS:

Bradley JS, et al. Clin Infect Dis. 2011

uBased on age, severity, local resistance

Community Acquired Pneumonia: Treatment

u Inpatient or Outpatient 1st line treatment: ¤Amoxicillin/ampicillin in infants and young children ¤Consider Macrolide (azithro) in kids > 5 u Ill patent or high-level PCN resistance: ¤3rd generation cephalosporin if suspect S. pneumo ¤Vancomycin if suspicion for MRSA ¤+Macrolides if suspicion high for M. pneumoniae

and C. pneumoniae

Bradley JS, et al. Clin Infect Dis. 2011

SLIDE 11

3/14/18 11

What is the RECOMMENDED next step?

A.

Obtain a PA and lateral CXR

B.

Obtain a blood culture and CBC

C.

Obtain a sputum culture

D.

Start PO amoxicillin and discharge with close follow up

E.

Start IV cefuroxime and admit

NAME THAT RASH

Toddler with fever, refusing po’s drooling…

Hand- foot-mouth disease (coxsackie virus)

Examples of “atypical coxsackie”

Eurosurveillance.org Pediatrics.aapublications.org

SLIDE 12

3/14/18 12

5 yo comes back from camp with fever, cough and runny nose, then develops rash proceeding head to toe

PHASE TIME COURSE DESCRIPTION Prodromal 2-3 days Fever + 3 C’s: cough, coryza (runny nose), conjunctivitis Exanthem 3-5 days Erythematous macules proceed cranial -> caudal. May become confluent. Koplik spots Recovery 5+ days Fever subsides and rash fades

Measles Measles Fast Facts

u Droplet/airborne spread, ~90% u 2 doses of vaccine = 97% effective u Dx by serology (IgM or rise in IgG) or PCR u High risk = <5yo or >20yo, pregnant,

immunocompromised

u Severe/fatal complications: ¤Encephalitis: 1/1000 ¤Resp/neurologic complication: 1-2/1000 ¤Subacute sclerosing panencephalitis (SSPE): rare u No specific treatment (vit A for severe illness)

9 mo old with high fever for 3 d, fever gone then w/rash on chest èhead

Roseola infantum

Typically caused by Human Herpes Virus (HHV) 6 or 7

SLIDE 13

3/14/18 13

10 mo old with rash on day 7 of amoxicillin for AOM

From: Consultant 360

Rash started on day 6 of treatment
Started truncally, spread to head and

extremities, including palms and soles

Not itchy, otherwise well

Amoxicillin Drug Eruption

u Delayed hypersensitivity (T-cell mediated,

Type IV) reaction

¤Morbilliform, often includes palms and soles,

day 5-10 of treatment

u NOT a drug allergy, and not associated with

advancement to anaphylaxis

¤Allergy = itchy, urticarial, within hours, may

progress

u May affect up to 10% of pedi pts treated

with amox or PCN

u Future use of amox NOT contraindicated

7 yo with fever, sore throat now with dry, diffuse rash most pronounced

n trunk and face

Group A Streptococcal “Scarlet Fever”

5 yo with temp of 39 for 5 days

SLIDE 14

3/14/18 14

Kawasaki Disease

uUnknown etiology (?ID?) uClinical diagnosis: Fever x5d = 4/5

clinical criteria

uSignificance: coronary artery aneurysms uTreatment: IVIG C (conjunctivitis) R (rash) A (adenopathy) S (strawberry tongue) H (hands and feet)

Unusual color names…

Xanadu Zaffre Amaranth

References

1. Greenhow TL, et al. The changing epidemiology of serious bacterial infections in young
infants. Pediatr Infect Dis Journal 2014; 33(6): 595-599
2. Roberts KB and the Subcommittee on Urinary Tract Infection, Steering Committee on Quality

Improvement and Management. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months.”

Pediatrics. 2011;128(3): 595–610
3. Lieberthal, A et al. The Diagnosis and Management of Acute Otitis Media. Pediatrics 2012;

131(3): e964-e999

4. Bradley, J. et al. The Management of Community- Acquired Pneumonia in Infants and

Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Disease Society of America. Clin Inf Dis. 2011; 53(7): e25-e76